Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,246 across all filing types
Latest filing 2020-08-28 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document is a newspaper advertisement of unaudited financial results for the quarter ended June 30, 2020, as stated in the subject line and body. It includes financial data such as earnings per share, equity share capital, total comprehensive income, net profit/loss, and total income from operations for the quarter and year ended March 31, 2020. The document references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and mentions the results are prepared according to Indian Accounting Standards (Ind AS). The presence of detailed financial figures and the quarterly period indicate this is a financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). The document length (15,000 characters) and detailed financial data confirm it is the report itself, not just an announcement or summary.
2020-08-28 English
Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies ....
Regulatory Filings
2020-08-28 English
Bliss GVS Pharma Ltd has informed BSE about Outcome of Board Meeting held on August 20, 2020.
Regulatory Filings
2020-08-20 English
Book Closure
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an intimation regarding the book closure dates for the purpose of the 35th Annual General Meeting (AGM) and final dividend for the financial year ended March 31, 2020. It references compliance with SEBI Listing Regulations and the Companies Act, 2013. The content is an announcement informing the stock exchanges and shareholders about the book closure period and related administrative details. It does not contain financial statements, detailed financial performance, or management discussion. The document is relatively short (5692 characters) and serves as a formal notification rather than a full report. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or possibly Regulatory Filings (RNS). However, since it specifically relates to book closure for AGM and dividend record date, it is more aligned with DVA, which covers official results and announcements related to shareholder meetings and voting rights. Confidence is high due to clear regulatory references and the nature of the content.
2020-08-20 English
Financial Result Updates
Regulatory Filings
2020-08-20 English
Pursuant to Section 91 of the Companies Act, 2013 ('Act'') and applicable Regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") ....
Regulatory Filings
2020-08-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.